¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

Á¦13ȸ ´ëÇѺ¹¸·¾ÏÇÐȸ Çмú½ÉÆ÷Áö¾ö : 2021-12-04

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
Á¦13ȸ ´ëÇѺ¹¸·¾ÏÇÐȸ Çмú½ÉÆ÷Áö¾ö : 2021-12-04
±³À°ÀÏÀÚ : 2021-12-04
±³À°Àå¼Ò : Ãµ¾È ½Å¶ó½ºÅ×ÀÌ  
±³À°ÁÖÁ¦ : Á¦13ȸ ´ëÇѺ¹¸·¾ÏÇÐȸ Çмú½ÉÆ÷Áö¾ö
ÁÖÃÖ±â°ü : ´ëÇѾÏÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇѺ¹¸·¾ÏÇÐȸ  
´ã´çÀÚ : ±èÇöÁ¤
¿¬¶ôó : 041-529-6186  
À̸ÞÀÏ : office@kspsm.or.kr      
±³À°Á¾·ù : ³»°ú, ¿Ü°ú, »êºÎÀΰú, ºñ´¢ÀÇÇаú, ¿µ»óÀÇÇаú, ¹æ»ç¼±Á¾¾çÇаú, Áø´Ü°Ë»çÀÇÇаú, º´¸®°ú, °¡Á¤ÀÇÇаú, ÇÙÀÇÇаú¿¹¹æÀÇÇÐ, »ý¸®ÇÐ, »ýÈ­ÇÐ, ºÐÀÚ»ý¹°ÇÐ, ¹Ì»ý¹°ÇÐ, ¾à¸®ÇÐ
Âü¼®¿¹»óÀοø : 50¸í
Èñ¸ÁÆòÁ¡ : 5Á¡  
Áö¿ª : Ãæû³²µµ
±³À°½Ã°£ : 5 ½Ã°£ 50ºÐ  
¼¼ºÎ¼ö°­·á : 40,000¿ø      
ºñ°í »çÀüµî·Ï: 4¸¸¿ø ÇöÀåµî·Ï: 5¸¸¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 12-04 ½Å¶ó½ºÅ×ÀÌ 09:10~09:30 Anatomy and physiology of the peritoneum  ¾Èżº(¼øõÇâ´ë) 
±³À°½Ã°£ 12-04 ½Å¶ó½ºÅ×ÀÌ 09:30~09:50 Peri-operative management to pervent complications  À̼ºÃ¶(´Ü±¹´ë) 
±³À°½Ã°£ 12-04 ½Å¶ó½ºÅ×ÀÌ 09:50~10:10 Immunological importance in peritoneal surface malignancy  ±è¿ì¶÷(Â÷ÀÇ´ë) 
±³À°½Ã°£ 12-04 ½Å¶ó½ºÅ×ÀÌ 10:10~10:30 Micro-tumor environment changes in advanced and recurrent epithelial ovarian cancer  ÀÌÁ¤À±(¿¬¼¼´ë) 
È޽Ġ12-04 ½Å¶ó½ºÅ×ÀÌ 10:30~10:50 Break time  () 
±³À°½Ã°£ 12-04 ½Å¶ó½ºÅ×ÀÌ 10:50~11:10 Principles in the treatment of colorectal cancer with peritoneal metastasis  ¹é½ÂÇõ(¿¬¼¼´ë) 
±³À°½Ã°£ 12-04 ½Å¶ó½ºÅ×ÀÌ 11:10~11:30 Update in PMCR from surgical point of view  ¹Ú¼ö¿¬(°æºÏ´ë) 
±³À°½Ã°£ 12-04 ½Å¶ó½ºÅ×ÀÌ 11:30~11:50 Update in PMCR from oncological point of view  ¹Ú¿µ¼®(»ï¼º¼­¿ïº´¿ø) 
±³À°½Ã°£ 12-04 ½Å¶ó½ºÅ×ÀÌ 11:50~12:10 Update in appendiceal cancer from pathological point of view  ÀÌ¿ø¾Ö(´Ü±¹´ë) 
½Ä»ç 12-04 ½Å¶ó½ºÅ×ÀÌ 12:10~13:00 Lunch Time  () 
±³À°½Ã°£ 12-04 ½Å¶ó½ºÅ×ÀÌ 13:00~13:30 Future perspective of the CRS/HIPEC as treatment modality for peritoneal surface malignancy  ¹Úµ¿±¹(´Ü±¹´ë) 
±³À°½Ã°£ 12-04 ½Å¶ó½ºÅ×ÀÌ 13:30~13:50 HIPEC/IP Chemotherapy Treatment Strategy with changing paradigm of molecular/immune therapy in frontline treatment of OC  ÀÓ¸íö(±¹¸³¾Ï¼¾ÅÍ) 
±³À°½Ã°£ 12-04 ½Å¶ó½ºÅ×ÀÌ 13:50~14:10 Surgery and HIPEC with changing paractice of melecular/immune therapy in recurrent OC  Àå¼®ÁØ(¾ÆÁÖ´ë) 
±³À°½Ã°£ 12-04 ½Å¶ó½ºÅ×ÀÌ 14:10~14:30 Recent advancement of HIPEC protocols in ovarian cancer  ¼Û¿ëÁß(ºÎ»ê´ë) 
±³À°½Ã°£ 12-04 ½Å¶ó½ºÅ×ÀÌ 14:30~14:50 Novel Clinical trials of HIPEC in peritoneal metastases from gynecologic malignancy  Dr. Sonke(Netherlands-¾Ï¼¾ÅÍ) 
È޽Ġ12-04 ½Å¶ó½ºÅ×ÀÌ 14:50~15:10 Break Time  () 
±³À°½Ã°£ 12-04 ½Å¶ó½ºÅ×ÀÌ 15:10~15:30 CT-Based Model to Predict Peritoneal Metastasis from Gastric Cancer  Á¤¿ì°æ(»ï¼º¼­¿ïº´¿ø) 
±³À°½Ã°£ 12-04 ½Å¶ó½ºÅ×ÀÌ 15:30~15:50 An Innovative Method of Treatment for Peritoneal Carcinomatosis in Gastric Cancer  ¹Î»çÈ«(Ãæ³²´ë) 
±³À°½Ã°£ 12-04 ½Å¶ó½ºÅ×ÀÌ 15:50~16:10 Intraperitoneal Chemotherapy for Peritoneal Metastasis in Gastric Cancer  ±èÁ¾ÇÑ(°í·Á´ë) 
±³À°½Ã°£ 12-04 ½Å¶ó½ºÅ×ÀÌ 16:10~16:30 Update of HIPEC(Hyperthermic Intraperitoneal Chemotherapy) for Gastric Cancer  Áö¿¹¼·(´Ü±¹´ë) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" Á¦13ȸ ´ëÇѺ¹¸·¾ÏÇÐȸ Çмú½ÉÆ÷Áö¾ö : 2021-12-04""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û 2021 ´ëÇѺñ¸¸ÇÐȸ ºÎ»ê°æ³²Áöȸ ¿Â,¿ÀÇÁ¶óÀÎ Çмú´ëȸ ¹× ¿¬¼ö°­Á : 2021-12-04
´ÙÀ½±Û (¿Â¶óÀÎ) Çѱ¹È£½ºÇǽº¡¤¿ÏÈ­ÀÇ·áÇÐȸ 2021 Á¤±âÃÑȸ ¹× µ¿°èÇмú´ëȸ : 2021-12-04
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
390 °æ±â ¾ÆÁÖ´ëÇб³º´¿ø 2018³â ¾ÆÁÖ´ëÇб³ ¸¶ÃëÅëÁõÀÇÇаú Ãß°è Çмú´ëȸ : 2018-09-01 0 1,244 2018-08-15
389 ¼­¿ï Çѱ¹ÁöÁú¤ýµ¿¸Æ°æÈ­ÇÐȸ Á¦7Â÷ International Congress on Lipid Metabolism & Atherosclerosis (ICoLA 2018) : 2018-09-01 0 578 2018-08-15
388 °æ³² â¿ø°æ»ó´ëÇб³º´¿ø 2018³â Áߺΰ泲 ¿¬¼ö±³À° : 2018-09-01 0 930 2018-08-15
387 °­¿ø Á¦19ȸ ´ëÇÑ Ã´Ãß¿Ü°úÇÐȸ ôÃßÅëÁõ¿¬±¸È¸ ½ÉÆ÷Áö¿ò : 2018-09-01 0 864 2018-08-15
386 ºÎ»ê Á¦15ȸºÎ¿ï°æÇǺΰúÀÇ»çȸÇмú´ëȸ : 2018-09-01 0 1,079 2018-08-15
385 ¼­¿ï 2018 ¼­¿ï¾Æ»êº´¿ø À̺ñÀÎÈÄ°ú Ãß°è ÀÓ»ó ¿öÅ©¼¥ : 2018-09-01 0 767 2018-08-15
384 ´ëÀü ´ëÇÑÁ¤Çü¿Ü°úÇÐȸ Á¤Çü¿Ü°úÁúȯ, ¼Õ»ó, Ä¡·á : 2018-09-01 0 1,472 2018-08-15
383 ¼­¿ï Preterm Birth International Collaborative Australasian(´ëÇÑ»êºÎÀΰúÇÐȸ&¼¼°èÁ¶»êÇÐȸ °øµ¿ÁÖ°ü) : 2018-08-31 0 1,136 2018-08-15
382 ¼­¿ï Çѱ¹Á÷¹«½ºÆ®·¹½ºÇÐȸ 2018³â ÇÏ°èÇмú´ëȸ : 2018-08-31 0 560 2018-08-15
381 ¼­¿ï Çѱ¹ÁöÁú¤ýµ¿¸Æ°æÈ­ÇÐȸ Á¦7Â÷ International Congress on Lipid Metabolism & Atherosclerosis (ICoLA 2018) : 2018-08-31 0 600 2018-08-15
380 ºÎ»ê ´ëÇѽŰæÁ¤½ÅÀÇÇÐȸ ºÎ»êÁöºÎÇÐȸ 8¿ù ¿ù·ÊÁý´ãȸ : 2018-08-30 0 1,256 2018-08-15
379 °­¿ø ¿øÁÖ ¼¼ºê¶õ½º ±âµ¶º´¿ø ±âÃʾȰúÁúȯ / CÇü °£¿° : 2018-08-29 0 2,246 2018-08-15
378 ¼­¿ï ´ëÇѼҾư¨¿°ÇÐȸ Á¦154Â÷ ¿ù·Ê¿¬¼ö°­ÁÂ(°¨¿°°ü¸® ¿¬¼ö±³À°) : 2018-08-28 0 630 2018-08-15
377 ¼­¿ï Á¦12ȸ ÁöµµÀü¹®ÀÇ Àü¹®ÇÐȸ(°¡Á¤ÀÇÇÐȸ) ±³À° : 2018-08-25 0 885 2018-08-15
376 ¼­¿ï Á¦13Â÷ ´ëÇѽŰæ¿Ü°úÇÐȸ ¼­¿ï°æÀÎ(°­¿ø-Á¦ÁÖ)Áöȸ : 2018-08-25 0 771 2018-08-15
1381 | 1382 | 1383 | 1384 | 1385 | 1386 | 1387 | 1388 | 1389 | 1390
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷